Anna Trullenque-Eriksson1, Blanca Guisado Moya. 1. *Private Practice, Bury St Edmunds, UK. †Professor of Oral Surgery, Department of Oral & Facial Medicine and Surgery, Faculty of Dentistry (UCM), Madrid, Spain.
Abstract
PURPOSE: This retrospective longitudinal study aims to assess long-term outcomes of osseointegrated dental implants placed in partially and totally edentulous patients. MATERIAL AND METHODS: Patients who were willing to sign the informed consent and attend a check-up were included. The prevalence of periimplant disease was calculated. Cases were further divided into mucositis or periimplantitis. Uni- and multi-variate statistical analyses were conducted to determine the influence of various factors. RESULTS: A total of 105 patients who had received 342 implants were included. Mean follow-up was 13.19 ± 3.70 years. The prevalence of periimplant disease was 14.2% of the analyzed implants and 21% of patients. An additional 4.8% of patients reported a previous presence of periimplant disease without current disease. The prevalence of mucositis and periimplantitis was 11.2% and 1.7%, respectively, of analyzed implants. Factors with possible influence on the presence of periimplant disease were gender, alcohol consumption, chemotherapy and/or head and neck radiotherapy, history of periodontal disease, and years of function. CONCLUSION: In our sample, periimplant disease was not infrequent, being present in 1 of 5 patients at the final check-up.
PURPOSE: This retrospective longitudinal study aims to assess long-term outcomes of osseointegrated dental implants placed in partially and totally edentulouspatients. MATERIAL AND METHODS:Patients who were willing to sign the informed consent and attend a check-up were included. The prevalence of periimplant disease was calculated. Cases were further divided into mucositis or periimplantitis. Uni- and multi-variate statistical analyses were conducted to determine the influence of various factors. RESULTS: A total of 105 patients who had received 342 implants were included. Mean follow-up was 13.19 ± 3.70 years. The prevalence of periimplant disease was 14.2% of the analyzed implants and 21% of patients. An additional 4.8% of patients reported a previous presence of periimplant disease without current disease. The prevalence of mucositis and periimplantitis was 11.2% and 1.7%, respectively, of analyzed implants. Factors with possible influence on the presence of periimplant disease were gender, alcohol consumption, chemotherapy and/or head and neck radiotherapy, history of periodontal disease, and years of function. CONCLUSION: In our sample, periimplant disease was not infrequent, being present in 1 of 5 patients at the final check-up.
Authors: Pedro Diaz; Esther Gonzalo; Luis J Gil Villagra; Barbara Miegimolle; Maria J Suarez Journal: BMC Oral Health Date: 2022-10-19 Impact factor: 3.747